Stricyte 1.4gm Injection
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Gemcitabine (1.4gm)
Overview Stricyte 1.4gm Injection
Oncaspar 1.4g injection is indicated for treating several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe complications. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. The medication may decrease blood cell counts, increasing infection risk, necessitating regular blood tests monitoring blood cells, heart, liver function, and uric acid levels. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infectives. Drug interactions are possible; disclose all medications to your doctor. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.
Primary Ingredients of Stricyte 1.4gm Injection
No text provided to rephrase.
Uses of Stricyte 1.4gm Injection
Lung cancer (non-small cell), breast cancer, pancreatic adenocarcinoma, bladder cancer, and ovarian carcinoma.
Major Benefits of Stricyte 1.4gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Stricyte 1.4gm Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Stricyte 1.4gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Stricyte 1.4gm Injection works:
Stricyte 1.4gm Injection inhibits cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential nucleotides. This action blocks further cancer cell growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Stricyte 1.4gm Injection and alcohol may result in heightened somnolence.
PregnancyCONSULT YOUR DOCTOR
Administration of Stricyte 1.4gm Injection is contraindicated during pregnancy due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician may deem its use justifiable if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingUNSAFE
Administration of Stricyte 1.4gm Injection is contraindicated while breastfeeding due to potential infant toxicity indicated by available data.
DrivingUNSAFE
Administration of Stricyte 1.4gm Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Stricyte 1.4gm Injection use in individuals with renal impairment is scarce. Physician consultation is recommended. Assessment of kidney function is advised prior to and during treatment with this medication.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Stricyte 1.4gm Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Stricyte 1.4gm Injection :
NA
Facts to Know About Stricyte 1.4gm Injection
| Label | Value |
|---|---|
| Chemical Type | Cytosine Analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Metabolic inhibitors |
3,018 People bought this recently